X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
INDRAPRASTHA MEDICAL Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Quarterly Results   (IRMED)

Here are the latest quarterly results of INDRAPRASTHA MEDICAL. For more details, see the INDRAPRASTHA MEDICAL financial fact sheet and INDRAPRASTHA MEDICAL share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

INDRAPRASTHA MEDICAL Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
3
Dec-16
3
Mar-17
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,9431,9131,8741,8421,9101,8411,8911,894 
Other income Rs m121211511 
Turnover Rs m1,9441,9151,8861,8431,9111,8461,8911,895 
Expenses Rs m1,7221,7311,7071,6731,7291,6611,6931,699 
Gross profit Rs m221182167169181179198195 
Depreciation Rs m7475837678777675 
Interest Rs m1921222123242118 
Profit before tax Rs m1298875738184102103 
Tax Rs m4731282529284638 
Profit after tax Rs m8157474852555665 
Gross profit margin %11.49.58.99.29.59.810.510.3 
Effective tax rate %36.834.837.234.735.534.045.436.8 
Net profit margin %4.23.02.52.62.73.03.03.4 
Diluted EPS Rs 0.9 0.6 0.5 0.5 0.6 0.6 0.6 0.7  
Diluted EPS (TTM) Rs 2.9 3.0 2.9 2.5 2.2 2.2 2.3 2.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: INDRAPRASTHA MEDICAL 1QFY19 Result Performance Review

More Health Services Company Quarterly Results:   FDC LTD.  DISHMAN PHARMA  ALEMBIC LTD  IPCA LABS  DIVIS LABORATORIES  

Compare INDRAPRASTHA MEDICAL With:   FDC LTD.  DISHMAN PHARMA  ALEMBIC LTD  IPCA LABS  DIVIS LABORATORIES  

Compare INDRAPRASTHA MEDICAL With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 383 Points Lower; Realty and Auto Stocks Drag(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Views on news

INDRAPRASTHA MEDICAL Announces Quarterly Results (1QFY19); Net Profit Up 36.2% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (up 36.2% YoY). Sales on the other hand came in at Rs 2 bn (up 2.8% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY18); Net Profit Up 19.3% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, INDRAPRASTHA MEDICAL has posted a net profit of Rs 56 m (up 19.3% YoY). Sales on the other hand came in at Rs 2 bn (up 0.9% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

This Market Crash could be the Biggest Wealth Creating Opportunity Since 2008(Profit Hunter)

Oct 8, 2018

While widespread fear is the friend of a value investor, serving up bargain purchases; personal fear is an investor's biggest enemy.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Are These Deep Corrections a Buying Signal?(Chart Of The Day)

Oct 5, 2018

The correction has bought many good companies to reasonable valuations. Go against the wisdom of crowd and Buy.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Oct 17, 2018 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL - APOLLO HOSPITALS COMPARISON

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS